The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.
Chiral Toxicology: It's the Same Thing…Only Different
Abstract
Chiral substances possess a unique architecture such that, despite sharing identical molecular formulas, atom-to-atom linkages, and bonding distances, they cannot be superimposed. Thus, in the environment of living systems, where specific structure-activity relationships may be required for effect (e.g., enzymes, receptors, transporters, and DNA), the physiochemical and biochemical properties of racemic mixtures and individual stereoisomers can differ significantly. In drug development, enantiomeric selection to maximize clinical effects or mitigate drug toxicity has yielded both success and failure. Further complicating genetic polymorphisms in drug disposition, stereoselective metabolism of chiral compounds can additionally influence pharmacokinetics, pharmacodynamics, and toxicity. Optically pure pharmaceuticals may undergo racemization in vivo, negating single enantiomer benefits or inducing unexpected effects. Appropriate chiral antidotes must be selected for therapeutic benefit and to minimize adverse events. Enantiomers may possess different carcinogenicity and teratogenicity. Environmental toxicology provides several examples in which compound bioaccumulation, persistence, and toxicity show chiral dependence. In forensic toxicology, chiral analysis has been applied to illicit drug preparations and biological specimens, with the potential to assist in determination of cause of death and aid in the correct interpretation of substance abuse and "doping" screens. Adrenergic agonists and antagonist, nonsteroidal anti-inflammatory agents, SSRIs, opioids, warfarin, valproate, thalidomide, retinoic acid, N-acetylcysteine, carnitine, penicillamine, leucovorin, glucarpidase, pesticides, polychlorinated biphenyls, phenylethylamines, and additional compounds will be discussed to illustrate important concepts in "chiral toxicology."
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Compendium of chemical terminology
Gold, V. (1987) · Cited by 2,525
Lammer, E. J., Chen, D. T., Hoar, R. M., Agnish, N. D., Benke, P. J., Braun, J. T., Curry, C. J., Fernhoff, P. M., Grix, A. W., Lott, I. T., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510033131401 · Cited by 1,942
Specification of Molecular Chirality
Cahn, R. S., Ingold, C., & Prelog, V. (1966) · Angewandte Chemie International Edition in English · doi:10.1002/anie.196603851 · Cited by 1,877
Waldo, A. L., Camm, A. J., deRuyter, H., Friedman, P. L., MacNeil, D. J., Pauls, J. F., Pitt, B., Pratt, C. M., Schwartz, P. J., & Veltri, E. P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)02149-6 · Cited by 1,371
Efficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen Overdose
Smilkstein, M. J., Knapp, G. L., Kulig, K. W., & Rumack, B. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812153192401 · Cited by 1,102
The specification of asymmetric configuration in organic chemistry
Cahn, R. S., Ingold, C. K., & Prelog, V. (1956) · Experientia · doi:10.1007/bf02157171 · Cited by 800
Human P450 metabolism of warfarin
Kaminsky, L. S., & Zhang, Z.-Y. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00140-4 · Cited by 798
Understanding and Managing Methotrexate Nephrotoxicity
Widemann, B. C., & Adamson, P. C. (2006) · The Oncologist · doi:10.1634/theoncologist.11-6-694 · Cited by 730
Anderson, J. L., Horne, B. D., Stevens, S. M., Grove, A. S., Barton, S., Nicholas, Z. P., Kahn, S. F. S., May, H. T., Samuelson, K. M., Muhlestein, J. B., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.737312 · Cited by 727
Buser, H.-R., Poiger, T., & Müller, M. D. (1999) · Environmental Science & Technology · doi:10.1021/es981014w · Cited by 676
The Anatomy of A-, B-, and Z-DNA
Dickerson, R. E., Drew, H. R., Conner, B. N., Wing, R. M., Fratini, A. V., & Kopka, M. L. (1982) · Science · doi:10.1126/science.7071593 · Cited by 663
Putting chirality to work: the strategy of chiral switches
Agranat, I., Caner, H., & Caldwell, J. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd915 · Cited by 637
Basic Principles of the CIP‐System and Proposals for a Revision
Prelog, V., & Helmchen, G. (1982) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198205671 · Cited by 592
Improvement by Acetylcysteine of Hemodynamics and Oxygen Transport in Fulminant Hepatic Failure
Harrison, P. M., Wendon, J. A., Gimson, A. E. S., Alexander, G. J. M., & Williams, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106273242604 · Cited by 585
FDA'S policy statement for the development of new stereoisomeric drugs
(1992) · Chirality · doi:10.1002/chir.530040513 · Cited by 581
Cardioprotective interventions for cancer patients receiving anthracyclines
van Dalen, E. C., Caron, H. N., Dickinson, H. O., & Kremer, L. C. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003917.pub4 · Cited by 553
PCB problems in the future: Foresight from current knowledge
Tanabe, S. (1988) · Environmental Pollution · doi:10.1016/0269-7491(88)90183-2 · Cited by 521
Prolonged Remissions of Cystic and Conglobate Acne with 13-cis-Retinoic Acid
Peck, G. L., Olsen, T. G., Yoder, F. W., Strauss, J. S., Downing, D. T., Pandya, M., Butkus, D., & Arnaud-Battandier, J. (1979) · New England Journal of Medicine · doi:10.1056/nejm197902153000701 · Cited by 519
International Union of Pharmacology. LXIII. Retinoid X receptors
Germain, P., Chambon, P., Eichele, G., Evans, R. M., Lazar, M. A., Leid, M., De Lera, A. R., Lotan, R., Mangelsdorf, D. J., & Gronemeyer, H. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.7 · Cited by 496
Keays, R., Harrison, P. M., Wendon, J. A., Forbes, A., Gove, C., Alexander, G. J., & Williams, R. (1991) · BMJ · doi:10.1136/bmj.303.6809.1026 · Cited by 488
The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function
Scheepers, A., Joost, H., & Schurmann, A. (2004) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607104028005364 · Cited by 476 · cited 8×
“L-Glucose does taste as sweet as D-glucose, presumably by presenting the same glycophore (two-dimensional surface part) to the taste receptor (Shallenberger, 1997).”
BackgroundInfluentialTrends in the development of chiral drugs
Caner, H., Groner, E., Levy, L., & Agranat, I. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02904-0 · Cited by 399
International Union of Pharmacology. LX. Retinoic Acid Receptors
Germain, P., Chambon, P., Eichele, G., Evans, R. M., Lazar, M. A., Leid, M., De Lera, A. R., Lotan, R., Mangelsdorf, D. J., & Gronemeyer, H. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.4 · Cited by 397
Review: The Pharmacology of Dobutamine
Ruffolo, R. R. (1987) · The American Journal of the Medical Sciences · doi:10.1097/00000441-198710000-00005 · Cited by 339
QTc Interval Screening in Methadone Treatment
Krantz, M. J., Martin, J., Stimmel, B., Mehta, D., & Haigney, M. C. P. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-6-200903170-00103 · Cited by 337
Role of Metabolism in Drug-Induced Idiosyncratic Hepatotoxicity
Walgren, J. L., Mitchell, M. D., & Thompson, D. C. (2005) · Critical Reviews in Toxicology · doi:10.1080/10408440590935620 · Cited by 322
Mechanisms of mercury disposition in the body
Clarkson, T. W., Vyas, J. B., & Ballatori, N. (2007) · American Journal of Industrial Medicine · doi:10.1002/ajim.20476 · Cited by 316
d‐Amino acids in the brain:d‐serine in neurotransmission and neurodegeneration
Wolosker, H., Dumin, E., Balan, L., & Foltyn, V. N. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06515.x · Cited by 309
Methylmercury transport across the blood-brain barrier by an amino acid carrier
Kerper, L. E., Ballatori, N., & Clarkson, T. W. (1992) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1992.262.5.r761 · Cited by 302
Clinical pharmacology of thalidomide
Eriksson, T., Björkman, S., & Höglund, P. (2001) · European Journal of Clinical Pharmacology · doi:10.1007/s002280100320 · Cited by 299
Nau, H., Hauck, R., & Ehlers, K. (1991) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1991.tb01303.x · Cited by 297
Collins, M. D., & Mao, G. E. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.399 · Cited by 288
Li, J., Zhang, G., Qi, S., Li, X., & Peng, X. (2006) · Science of The Total Environment · doi:10.1016/j.scitotenv.2006.09.023 · Cited by 276
Stanley, J. K., Ramirez, A. J., Chambliss, C. K., & Brooks, B. W. (2007) · Chemosphere · doi:10.1016/j.chemosphere.2007.04.080 · Cited by 255
Eap, C. B., Crettol, S., Rougier, J.-S., Schläpfer, J., Sintra Grilo, L., Déglon, J.-J., Besson, J., Croquette-Krokar, M., Carrupt, P.-A., & Abriel, H. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100120 · Cited by 255
Selective degradation of ibuprofen and clofibric acid in two model river biofilm systems
Winkler, M. (2001) · Water Research · doi:10.1016/s0043-1354(01)00026-4 · Cited by 233
Ehret, G. B., Voide, C., Gex-Fabry, M., Chabert, J., Shah, D., Broers, B., Piguet, V., Musset, T., Gaspoz, J.-M., Perrier, A., et al. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.12.1280 · Cited by 233
Aoki, Y. (2001) · Environmental Research · doi:10.1006/enrs.2001.4244 · Cited by 231
Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment
CRETTOL, S., DEGLON, J., BESSON, J., CROQUETTEKROKKAR, M., GOTHUEY, I., HAMMIG, R., MONNAT, M., HUTTEMANN, H., BAUMANN, P., & EAP, C. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.08.011 · Cited by 228
Stereoselective metabolism of methadone N‐demethylation by cytochrome P4502B6 and 2C19
Gerber, J. G., Rhodes, R. J., & Gal, J. (2004) · Chirality · doi:10.1002/chir.10303 · Cited by 228
Pearson, E. C., & Woosley, R. L. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1112 · Cited by 225
Chromatographische Racemattrennung
Blaschke, G. (1980) · Angewandte Chemie · doi:10.1002/ange.19800920105 · Cited by 224
Damaj, M. I., Carroll, F. I., Eaton, J. B., Navarro, H. A., Blough, B. E., Mirza, S., Lukas, R. J., & Martin, B. R. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001313 · Cited by 212
Corcoran, G. B., & Wong, B. K. (1986) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)25048-0 · Cited by 202
McCaffery, P. J., Adams, J., Maden, M., & Rosa‐Molinar, E. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02765.x · Cited by 202
Unconventional ligands and modulators of nicotinic receptors
Pereira, E. F. R., Hilmas, C., Santos, M. D., Alkondon, M., Maelicke, A., & Albuquerque, E. X. (2002) · Journal of Neurobiology · doi:10.1002/neu.10146 · Cited by 201
Toxicity and Teratogenicity of Optical Isomers of Thalidomide
FABRO, S., SMITH, R. L., & WILLIAMS, R. T. (1967) · Nature · doi:10.1038/215296a0 · Cited by 200
Environmental fate processes and biochemical transformations of chiral emerging organic pollutants
Wong, C. S. (2006) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-006-0424-3 · Cited by 199
Comeau, F., Surette, C., Brun, G. L., & Losier, R. (2008) · Science of The Total Environment · doi:10.1016/j.scitotenv.2008.02.031 · Cited by 193
TRANYLCYPROMINE IN MULTIPLE SCLEROSIS
(1965) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1965.tb18309.x · Cited by 192
Schulze, J. J., Lundmark, J., Garle, M., Skilving, I., Ekström, L., & Rane, A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0218 · Cited by 186
Use of the Chiral Pharmaceutical Propranolol to Identify Sewage Discharges into Surface Waters
Fono, L. J., & Sedlak, D. L. (2005) · Environmental Science & Technology · doi:10.1021/es047965t · Cited by 178
Lheureux (2005) · doi:10.1186/cc3742 · Cited by 176
Rowe, A. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00101-x · Cited by 174
Piper, T., Mareck, U., Geyer, H., Flenker, U., Thevis, M., Platen, P., & Schänzer, W. (2008) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.3601 · Cited by 169
Konwick, B. J., Garrison, A. W., Black, M. C., Avants, J. K., & Fisk, A. T. (2006) · Environmental Science & Technology · doi:10.1021/es0600678 · Cited by 160
First trimester topical tretinoin and congenital disorders
Jick, S. S., Terris, B. Z., & Jick, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)91004-6 · Cited by 160
Human pharmacology of the methamphetamine stereoisomers
Mendelson, J. E., Uemura, N., Harris, D. E., NATH, R., FERNANDEZ, E., JACOBIII, P., Everhart, E. T., & JONES, R. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.06.013 · Cited by 158
Nikolai, L. N., McClure, E. L., MacLeod, S. L., & Wong, C. S. (2006) · Journal of Chromatography A · doi:10.1016/j.chroma.2006.07.033 · Cited by 156
Topical Retinoids in Acne Vulgaris: Update on Efficacy and Safety
Thielitz, A., & Gollnick, H. P. M. (2008) · American Journal of Clinical Dermatology · doi:10.2165/0128071-200809060-00003 · Cited by 154
Ihmsen, H., Geißlinger, G., & Schüttler, J. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.119722 · Cited by 154
Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics
Brocks, D. R. (2006) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.517 · Cited by 147
Reist, M., Carrupt, P., Francotte, E. R., & Testa, B. (1998) · Chemical Research in Toxicology · doi:10.1021/tx9801817 · Cited by 145
Enantiospecific toxicity of the β-blocker propranolol to Daphnia magna and Pimephales promelas
Stanley, J. K., Ramirez, A. J., Mottaleb, M. A., Chambliss, C. K., & Brooks, B. W. (2006) · Environmental Toxicology and Chemistry · doi:10.1897/05-298r1.1 · Cited by 135
Chemopreventive properties and mechanisms ofN-acetylcysteine. The experimental background
Flora, S. D., Cesarone, C. F., Balansky, R. M., et al. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240590806 · Cited by 134
The Pharmocogenomics of Warfarin: Closing in on Personalized Medicine
Rettie, A. E. (2006) · Molecular Interventions · doi:10.1124/mi.6.4.8 · Cited by 132
Gal, J. (2007) · Chirality · doi:10.1002/chir.20494 · Cited by 125
Keaveney, M., & Stunnenberg, H. G. (1995) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4684-6837-3_7 · Cited by 121
Levels and chiral signatures of persistent organochlorine pollutants in human tissues from Belgium
Chu, S., Covaci, A., & Schepens, P. (2003) · Environmental Research · doi:10.1016/s0013-9351(03)00016-1 · Cited by 121
Pharmaceutical residues in the river Rhine—results of a one-decade monitoring programme
Sacher, F., Ehmann, M., Gabriel, S., Graf, C., & Brauch, H. (2008) · Journal of Environmental Monitoring · doi:10.1039/b800701b · Cited by 121
ILLEGAL OR LEGITIMATE USE? PRECURSOR COMPOUNDS TO AMPHETAMINE AND METHAMPHETAMINE
MUSSHOFF, F. (2000) · Drug Metabolism Reviews · doi:10.1081/dmr-100100562 · Cited by 116
High glucose-induced replicative senescence: point of no return and effect of telomerase
Blazer, S., Khankin, E., Segev, Y., Ofir, R., Yalon-Hacohen, M., Kra-Oz, Z., Gottfried, Y., Larisch, S., & Skorecki, K. L. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00818-5 · Cited by 113
Toxicity of fipronil and its enantiomers to marine and freshwater non-targets
Overmyer, J. P., Rouse, D. R., Avants, J. K., Garrison, A. W., DeLorenzo, M. E., Chung, K. W., Key, P. B., Wilson, W. A., & Black, M. C. (2007) · Journal of Environmental Science and Health Part B · doi:10.1080/03601230701391823 · Cited by 111
Chirality in antirheumatic drugs
Kean, W. F., Howard-Lock, H. E., & Lock, C. J. L. (1991) · The Lancet · doi:10.1016/0140-6736(91)92382-c · Cited by 111
Role of racemization in optically active drugs development
Ali, I., Gupta, V. K., Aboul-Enein, H. Y., Singh, P. K., & Sharma, B. (2007) · Chirality · doi:10.1002/chir.20397 · Cited by 111
Stereoselective binding of propranolol to human plasma, α1-acid glycoprotein, and albumin
Walle, U. K., Walle, T., Bai, S. A., & Olanoff, L. S. (1983) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1983.240 · Cited by 110
The human DNA repair factor XPC‐HR23B distinguishes stereoisomeric benzo[a]pyrenyl‐DNA lesions
Mocquet, V., Kropachev, K. Y., Kolbanovskiy, M., Kolbanovskiy, A., Tapias, A., Cai, Y., Broyde, S. B., Geacintov, N. E., & Egly, J. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601730 · Cited by 110
Pharmacogenomics of 4-Hydroxycoumarin Anticoagulants
Au, N. T., & Rettie, A. E. (2008) · Drug Metabolism Reviews · doi:10.1080/03602530801952187 · Cited by 110
Docking Studies Show That D-Glucose and Quercetin Slide through the Transporter GLUT1
Cunningham, P., Afzal‐Ahmed, I., & Naftalin, R. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509422200 · Cited by 107
Hasinoff, B. B., Kuschak, T. I., Yalowich, J. C., & Creighton, A. M. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00218-o · Cited by 106
Chiral Inversion of Drugs: Coincidence or Principle?
Wsól, V., Skálová, L., & Szotáková, B. (2004) · Current Drug Metabolism · doi:10.2174/1389200043335360 · Cited by 105
High-Dose Leucovorin as Sole Therapy for Methotrexate Toxicity
Flombaum, C. D., & Meyers, P. A. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1589 · Cited by 103
Fine, K. D., Ana, C. A. S., Porter, J. L., & Fordtran, J. S. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90957-e · Cited by 100
Chapter 5 Structure and Function of the Reduced Folate Carrier
Matherly, L. H., & Hou, Z. (2008) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00405-6 · Cited by 96
Role of CYP2D6 in the stereoselective disposition of venlafaxine in humans.
Eap, C. B., Lessard, E., Baumann, P., Brawand-Amey, M., Yessine, M., O’Hara, G. E., & Turgeon, J. (2003) · Pharmacogenetics · doi:10.1097/00008571-200301000-00006 · Cited by 95
Eriksson, T., Björkman, S. E., Roth, B., & Höglund, P. (2000) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357001774660 · Cited by 94
Yamada, T., Okada, T., Sakaguchi, K., Ohfune, Y., Ueki, H., & Soloshonok, V. A. (2006) · Organic Letters · doi:10.1021/ol0623668 · Cited by 93
Enantioselective Degradation and Chiral Stability of Pyrethroids in Soil and Sediment
Qin, S., Budd, R., Bondarenko, S., Liu, W., & Gan, J. (2006) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf060329p · Cited by 93
Hathcock, J. N., & Shao, A. E. (2006) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2006.06.007 · Cited by 92
Location of the Retinal Chromophore in the Activated State of Rhodopsin
Ahuja, S., Crocker, E., Eilers, M., Horn̆ák, V., Hirshfeld, A., Ziliox, M., Syrett, N., Reeves, P. J., Khorana, H. G., Sheves, M., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805725200 · Cited by 92
Self-citationLoureiro, K. D., Kao, K. K., Jones, K. L., Alvarado, S. N. A., Chavez, C., Dick, L. M., Felix, R. J., Johnson, D., & Chambers, C. (2005) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30744 · Cited by 87
Neupert, W., Brugger, R., Euchenhofer, C., Brune, K., & Geißlinger, G. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701415 · Cited by 83
Pessah, I. N., Lehmler, H., Robertson, L. W., Pérez, C. F., Cabrales, E., Bose, D. D., & Feng, W. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800328u · Cited by 80
Warfarin: Metabolism and mode of action
Park, B. K. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90750-2 · Cited by 77
Enantiomers in arthritic disorders
Williams, K. M. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90095-j · Cited by 76
Pham, Y.-T., Régina, A., Farinotti, R., Couraud, P., Wainer, I. W., Roux, F. S., & Gimenez, F. (2000) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(00)00160-4 · Cited by 75
Kharasch, E. D., Mitchell, D., & Coles, R. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008314254 · Cited by 72
Pictet, A., & Rotschy, A. (1904) · Berichte der deutschen chemischen Gesellschaft · doi:10.1002/cber.19040370206 · Cited by 71
Absorption of d- and l-carnitine by the intestine and kidney tubule in the rat
Gross, C. J., & Henderson, L. M. (1984) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(84)90046-4 · Cited by 69
Biodegradation and chiral stability of fipronil in aerobic and flooded paddy soils
TAN, H., CAO, Y., TANG, T., et al. (2008) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2008.08.007 · Cited by 69
Impact of Stereoselectivity on the Pharmacokinetics and Pharmacodynamics of Antiarrhythmic Drugs
Mehvar, R., Brocks, D., & Vakily, M. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241080-00001 · Cited by 68
Morley, N., Curnow, A., Salter, L. F., Campbell, S. J., & Gould, D. J. (2003) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2003.06.004 · Cited by 68
Baker, G. B., & Prior, T. I. (2002) · Annals of Medicine · doi:10.1080/078538902321117742 · Cited by 68
A Double-Blind Study of the Sedative Effects of the Thalidomide Enantiomers in Humans
Höglund, P., Eriksson, T., & Björkman, S. E. (1998) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1023/a:1021008016719 · Cited by 67
Restless Legs Syndrome Induced by Escitalopram: Case Report and Review of the Literature
Page, R. L., II, Ruscin, J. M., Bainbridge, J. L., & Brieke, A. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.2.271 · Cited by 66
Safety of first-trimester exposure to topical tretinoin: prospective cohort study
Shapiro, L. E., Pastuszak, A. L., Curto, G., & Koren, G. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63790-7 · Cited by 64
The Uptake of Carnitine by Slices of Rat Cerebral Cortex
Huth, P. J., Schmidt, M. J., Hall, P. V., Fariello, R. G., & Shug, A. L. (1981) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1981.tb01647.x · Cited by 61
Knihinicki, R. D., Day, R. O., & Williams, K. M. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90588-v · Cited by 61
Ando, Y., Price, D. K., Dahut, W. L., Cox, M. C., Reed, E., & Figg, W. D. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.318 · Cited by 61
Adams, J. (1993) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(93)90015-g · Cited by 59
Rebouche, C. J. (1983) · The Journal of Nutrition · doi:10.1093/jn/113.10.1906 · Cited by 57
Jones, W. J., Mazur, C. S., Kenneke, J. F., & Garrison, A. W. (2007) · Environmental Science and Technology · doi:10.1021/es071409s · Cited by 57
D ‐SAP: A New, Noncytotoxic, and Fully Protease Resistant Cell‐Penetrating Peptide
Pujals, S., Fernández‐Carneado, J., Ludevid, M. D., & Giralt, E. (2007) · ChemMedChem · doi:10.1002/cmdc.200700267 · Cited by 57
Cody, J. T. (2002) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-200205000-00012 · Cited by 55
Carnitine as an antidote for acute valproate toxicity in children
Russell, S. (2007) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32805e879a · Cited by 55
DL-Penicillamine as a Cause of Optic Axial Neuritis
Tu, J.-B. (1963) · JAMA · doi:10.1001/jama.1963.03060020043019 · Cited by 53
Yu, Q., Pei, X., Holloway, H. W., Greig, N. H., & Brossi, A. R. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970210v · Cited by 52
Boening, D. W. (1998) · Ecotoxicology and Environmental Safety · doi:10.1006/eesa.1997.1608 · Cited by 51
Stereoisomers and Drug Toxicity
SCOTT, A. K. (1993) · Drug Safety · doi:10.2165/00002018-199308020-00005 · Cited by 51
Majerus, T. C., Dasta, J. F., Bauman, J. L., Danziger, L. H., & Ruffolo, R. R., Jr. (1989) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1989.tb04133.x · Cited by 51
Asher, B. J., Wong, C. S., & Rodenburg, L. A. (2007) · Environmental Science & Technology · doi:10.1021/es070763n · Cited by 49
The enantiomers of the teratogenic thalidomide analogue EM 12
Schmahl, H., Nau, H., & Neubert, D. (1988) · Archives of Toxicology · doi:10.1007/bf00570140 · Cited by 49
Chen, Y. L., Nielsen, J., Hedberg, K., Dunaiskis, A. R., Jones, S., Russo, L., Johnson, J., Ives, J., & Liston, D. R. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00086a011 · Cited by 49
Induction of the homeotic gene Hoxa1 through valproic acid's teratogenic mechanism of action
Stodgell, C., Ingram, J. L., O’Bara, M. A., Tisdale, B., Nau, H., & Rodier, P. M. (2006) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2006.08.004 · Cited by 48
Tsoko, M., Beauseigneur, F., Gresti, J., Niot, I., Demarquoy, J., Boichot, J., Bezard, J. A., Rochette, L., & Clouet, P. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00019-v · Cited by 48
Dehennin, L. (1994) · Journal of Endocrinology · doi:10.1677/joe.0.1420353 · Cited by 48
Therapeutic Drug Monitoring of Escitalopram in an Outpatient Setting
Reis, M., Chermà, M. D., Björn Carlsson, A., & Bengtsson, F. (2007) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e31815b3f62 · Cited by 46
Buser, H.-R., Müller, M. D., Balmer, M. E., Poiger, T., & Buerge, I. J. (2005) · Environmental Science & Technology · doi:10.1021/es048265r · Cited by 46
Claessens, Y.-É., Cariou, A., Monchi, M., Soufir, L., Azoulay, É., Rouges, P., Goldgran-Tolédano, D., Branche, F., & Dhainaut, J.-F. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000053649.69377.08 · Cited by 45
Klug, S., Felies, A., Stürje, H., Nogueira, A. C. D. A., Neubert, R. T., & FRANKUS, E. (1994) · Archives of Toxicology · doi:10.1007/s002040050055 · Cited by 44
Liu, J., & Liu, R. H. (2002) · Journal of Biochemical and Biophysical Methods · doi:10.1016/s0165-022x(02)00136-7 · Cited by 44
Heger, W., Schmahl, H., Klug, S., Felies, A., Nau, H., Merker, H., & Neubert, D. (1994) · Teratogenesis Carcinogenesis and Mutagenesis · doi:10.1002/tcm.1770140303 · Cited by 39
Teo, S. K., Chen, Y., Muller, G. W., Chen, R. S., Thomas, S. D., Stirling, D., & Chandula, R. S. (2003) · Chirality · doi:10.1002/chir.10221 · Cited by 39
Vigabatrin: A Novel Therapy for Seizure Disorders
Gidal, B. E., Privitera, M., Sheth, R. D., & Gilman, J. T. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18376 · Cited by 39
Busch, E. M., Gorgels, T. G. M. F., Roberts, J. E., & Norren, D. V. (1999) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1999.tb08148.x · Cited by 37
Hyponatremia Associated with Escitalopram
Covyeou, J. A., & Jackson, C. W. (2007) · New England Journal of Medicine · doi:10.1056/nejmc062840 · Cited by 34
Enantioselective Chronic Toxicity of Fipronil to Ceriodaphnia dubia
Wilson, W. A., Konwick, B. J., Garrison, A. W., et al. (2007) · Archives of Environmental Contamination and Toxicology · doi:10.1007/s00244-007-9003-7 · Cited by 34
Matsuoka, M., & Igisu, H. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90360-9 · Cited by 34
The insecticide fipronil and its metabolite fipronil sulphone inhibit the rat α1β2γ2L GABAAreceptor
Li, P., & Akk, G. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.309 · Cited by 33
Environmental Impact of Fipronil to the Louisiana Crawfish Industry
Bedient, P. B., Horsak, R. D., Schlenk, D., et al. (2005) · Environmental Forensics · doi:10.1080/15275920500194530 · Cited by 33
Effects of N-acetylcysteine stereoisomers on oxygen-induced lung injury in rats
Särnstrand, B., Tunek, A., Sjödin, K., & Hallberg, A. (1995) · Chemico-Biological Interactions · doi:10.1016/0009-2797(94)03332-3 · Cited by 32
Susceptibilityin uteroand upon neonatal exposure
Dencker, L., & Eriksson, P. O. (1998) · Food Additives & Contaminants · doi:10.1080/02652039809374613 · Cited by 31
Contrast Medium‐Induced Nephropathy: Strategies for Prevention
Massicotte, A. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.9.1140 · Cited by 31
Can We Ensure the Safe Use of Known Human Teratogens?
Honein, M. A., Lindstrom, J. A., & Kweder, S. L. (2007) · Drug Safety · doi:10.2165/00002018-200730010-00002 · Cited by 31
MYASTHENIA-LIKE SYNDROME AFTER D,L- BUT NOT L-CARNITINE
Bazzato, G., Coli, U., Landini, S., Mezzina, C., & Ciman, M. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92372-2 · Cited by 30
Stereoselective Oxidation and Glucuronidation of Carvedilol in Human Liver and Intestinal Microsomes
Ishida, K., Taira, S., Morishita, H., Kayano, Y., Taguchi, M., & Hashimoto, Y. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.1297 · Cited by 30
Interspecies differences in stereoselective protein binding and clearance of MK-571.
Tocco, D. J., Deluna, F. A., Duncan, A. E., Hsieh, J. H., & Lin, J. H. (1990) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08529-0 · Cited by 30
d -Glucose upregulates adenosine transport in cultured human aortic smooth muscle cells
Leung, G., Man, R. Y. K., & Tse, C. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00921.2004 · Cited by 29
Newman, C. M., Warren, J. B., Taylor, G. W., Boobis, A. R., & Davies, D. S. (1990) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1990.tb13014.x · Cited by 27
Schwartz, J. B., Capili, H., & Wainer, I. W. (1994) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1994.151 · Cited by 27
Militante, J. D., Ma, B.-W., Akk, G., & Steinbach, J. H. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.047134 · Cited by 27
Serotonin Syndrome Associated with the Use of Escitalopram
Huska, M. T., Catalano, G., & Catalano, M. C. (2007) · CNS Spectrums · doi:10.1017/s1092852900021027 · Cited by 27
Andrews, J. E., Ebron‐McCoy, M. T., Bojic, U., et al. (1995) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1995.1112 · Cited by 25
Heydorn, S., Menné, T., Andersen, K. E., Bruze, M., Svedman, C., Basketter, D. A., & Johansen, J. D. (2003) · Contact Dermatitis · doi:10.1034/j.1600-0536.2003.00145.x · Cited by 25
Eikel, D., Hoffmann, K., Zoll, K., Lampen, A., & Nau, H. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008078 · Cited by 24
Role of acetyl-l-carnitine in the brain: revealed by Bioradiography
Tanaka, M., Nakamura, F., Mizokawa, S., Matsumura, A., Matsumura, K., & Watanabe, Y. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01103-3 · Cited by 23
Stereoselective regulation of MDR1 expression in Caco‐2 cells by cetirizine enantiomers
Shen, S., He, Y. Z., & Zeng, S. (2007) · Chirality · doi:10.1002/chir.20400 · Cited by 22
Benedetti, M. S., Whomsley, R., Mathy, F., Jacques, P., Espié, P., & Canning, M. (2007) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2007.00543.x · Cited by 21
Catatonia Is a Risk Factor for Neuroleptic Malignant Syndrome
Carroll, B. T., & Lee, J. W. Y. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1219d · Cited by 17
Busch, E. M., Gorgels, T. G. M. F., Roberts, J. E., & Norren, D. V. (1999) · Photochemistry and Photobiology · doi:10.1562/0031-8655(1999)070<0353:teotso>2.3.co;2 · Cited by 17
Influence of D‐ and L‐glucose on erythrocytes and blood viscosity
Bühler, I., Walter, R. B., & Reinhart, W. H. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00769.x · Cited by 16
Identification of famprofazone ingestion
Mußhoff, F., & Kræmer, T. (1998) · International Journal of Legal Medicine · doi:10.1007/s004140050176 · Cited by 16
Lu, L., Leonessa, F., Baynham, M. T., Clarke, R. C., Gimenez, F., Pham, Y.-T., Roux, F. S., & Wainer, I. W. (2001) · Pharmaceutical Research · doi:10.1023/a:1013098213770 · Cited by 13
K�lliker, S., & Oehme, M. (2004) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-003-2411-2 · Cited by 12
Bordajandi, L. R., & González, M. J. (2008) · Journal of Dairy Science · doi:10.3168/jds.2007-0577 · Cited by 12
Escitalopram-Associated Serotonin Toxicity
Vari, G., & Beckson, M. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000264977.64120.43 · Cited by 8
Wong, B. K., Galinsky, R. E., & Corcoran, G. B. (1986) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600750910 · Cited by 8
Plasma S/R ratio of warfarin co-varies with VKORC1 haplotype
Osman, A., Enström, C., & Lindahl, T. L. (2007) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e3280444bfd · Cited by 7
Engel, J., Kristen, G., Schaefer, A., & Schlichtegroll, A. V. (1986) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(86)90010-4 · Cited by 7
Lin, M., Hwang, M., Chang, H., et al. (2007) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20202 · Cited by 6
Transitory l-carnitine depletion in rat skeletal muscle by d-carnitine
Arancio, O., Bonadonna, G., Calvani, M., Giovene, P., Tomelleri, G., & Grandis, D. D. (1989) · Pharmacological Research · doi:10.1016/1043-6618(89)90234-x · Cited by 2
Cited by
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011
Hiemke, C., Baumann, P., Bergemann, N., Conca, A., Dietmaier, O., Egberts, K., Fric, M., Gerlach, M., Greiner, C., Gründer, G., et al. (2011) · Pharmacopsychiatry · doi:10.1055/s-0031-1286287 · Cited by 868
Applications of Deuterium in Medicinal Chemistry
Pirali, T., Serafini, M., Cargnin, S., & Genazzani, A. A. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01808 · Cited by 855
Chiral 2D Perovskites with a High Degree of Circularly Polarized Photoluminescence
Ma, J., Fang, C., Chen, C., Jin, L., Wang, J., Wang, S., Tang, J., & Li, D. (2019) · ACS Nano · doi:10.1021/acsnano.9b00302 · Cited by 581
Endocrine Disruptors and Asthma-Associated Chemicals in Consumer Products
Dodson, R. E., Nishioka, M., Standley, L. J., Perovich, L. J., Brody, J. G., & Rudel, R. A. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1104052 · Cited by 542
Metadata
- Authors
- Smith, S. W.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-05-04
- Volume
- 110
- Issue
- 1
- Pages
- 4-30
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2163008413
- Cited by
- 602
- References
- 172
- FWCI
- 8.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.